Certolizumab pegol has a different profile from other anti-TNFs, including golimumab, in a variety of in vitro assays

Abstract

This research paper explore the methodology and findings associated with Journal of Translational Medicine. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).